Russel Schilder, MD

Dr. Schilder is consulting Medical Director at Context Therapeutics. He was previously Director of the Gynecologic Medical Oncology Program at the Kimmel Cancer Center at Jefferson. Prior to his arrival at Thomas Jefferson University Hospital, Dr. Schilder served as a professor in the Department of Medical Oncology and Chief of Gynecologic Medical Oncology at Fox Chase Cancer Center. Dr. Schilder’s research interests include evaluating new treatments for gynecologic malignancies and conducting phase I trials for new drug development. He has written more than 150 book chapters, articles, and abstracts. Dr. Schilder is the former NRG Developmental Therapeutics Gynecologic Cancer Phase I Subcommittee Chair, served on the Steering Committee of NCI CTEP Gynecologic Cancer, and Chaired the ECOG/ACRIN Gynecologic Committee.

A graduate of Rutgers University, Dr. Schilder received both his M.S. and medical degree from the University of Miami. Dr. Schilder’s postgraduate training began at Temple University Hospital with an internship and residency in Internal Medicine. He completed a joint hematology and oncology fellowship at Temple University Hospital and Fox Chase Cancer Center.